Development and validation of a stability indicating method for the enantioselective estimation of omeprazole enantiomers in the enteric-coated formulations by high-performance liquid chromatography

Journal of Pharmacy and Bioallied Sciences

Volumn 3, Issue 2, 2011, Pages 310-314

  Vyas, Samir ^a   Patel, Ajay ^a   Ladva, Kartik ^b   Joshi, H ^c   Bapodra, Atul ^d  

^a Department of Analytical Development   (India)

^b Shree M and N Virani Science College   (India)

^c SAURASHTRA UNIVERSITY   (India)

^d M D Science College   (India)

Author keywords

Enantiomeric purity; method development, normal phase chiral HPLC; omeprazole; pharmaceutical formulations, validation

Indexed keywords

OMEPRAZOLE;

ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; ENANTIOMER; ENANTIOSELECTIVITY; ENTERIC COATED TABLET; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; ROOM TEMPERATURE; VALIDATION PROCESS;

EID: 79957567772     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.80766     Document Type: Article

References (13)

1. von Unge S, Langer V, Sjolin L. Stereochemical assignment of the enantiomers of omeprazole from X-ray analysis of a fenchyloxymethyl derivative of (+)-(R)-omeprazole. Tetrahedron Asymmetry 1997;8:1967-70. (Pubitemid 27277918)
2. Abelö A, Andersson TB, Antonsson M, Naudot AK, Skånberg I, Weidolf L. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes. Drug Metab Dispos 2000;28:966-72. (Pubitemid 30612617)
3. Mathew M, Das Gupta V, Bailey RE. Stability of omeprazole solutions at various ph values as determined by high-performance liquid chromatography. Drug Dev Ind Pharm 1995;21:965-71.
4. Agatonovic-Kustrin S, Williams D, Ibrahim N, Glass BD. Influence of sulfobutylether-β-cyclodextrin on the stability of S- and R- omeprazole. Curr Drug Discov Technol 2007;4:192-7.
5. Erickson M, Josefsson L. Pharmaceutical Formulation for Omeprazole, AstraZeneca. US Patent Number 6,090,827 (2000).
6. Scarpignato C, Pelosini I. Review article: The opportunities and benefits of extended acid suppression. Aliment Pharmacol Ther 2006;23:23-34. (Pubitemid 44383833)
7. Bonato PS, Paias FO. Enantioselective analysis of omeprazole in pharmaceutical formulations by chiral high-performance liquid chromatography and capillary electrophoresis. J Pharm Biomed Sci 2004;15:318-23. (Pubitemid 39077713)
8. ICH - international conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Validation of analytical Procedure: Text and Methodology ICH Secretariat. Geneva, Switzerland:ICH; 1996.
9. International Conference on Harmonization (ICH). Validation of Analytical Procedures: Definitions and Terminology. Geneva, Switzerland: ICH; 1995. Q2A (CPMP/ICH/381/95).
10. International Conference on Harmonization (ICH). Validation of Analytical Procedures: Methodology. Geneva, Switzerland: ICH; 1995. Q2B (CPMP/ICH/281/95).
11. Wainer IW, Stiffin RM, Shibata T. Resolution of enantiomeric aromatic alcohols on a cellulose tribenzoate high-performance liquid chromatography chiral stationary phase: A proposed chiral recognition mechanism. J Chromatogr A 1987;441:139.
12. Cirilli R, Ferretti R, Gallinella B, De Santis E, Zanitti L, La Torre F. High-performance liquid chromatography enantioseparation of proton, pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions. J Chromatogr A 2008;1177:105-13. (Pubitemid 350256753)
13. Belaz KR, Coimbra M, Barreiro JC, Montanari CA, Cass QB. Multimilligram enantioresolution of sulfoxide proton pump inhibitors by liquid chromatography on polysaccharide-based chiral stationary phase. J Pharm Biomed Anal 2008;47:81-7.